Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK

Following the emergence of a new variant of Creutzfeldt-Jakob disease (vCJD) 6 years ago, and the gradual rise in clinical cases, there has been increased speculation regarding the overall magnitude of this epidemic in Great Britain. In this paper, we explore the epidemiological factors and uncertainties determining the scale of this epidemic in light of the most recent data on reported vCJD mortality. Our results demonstrate that, while the magnitude of the uncertainty has decreased dramatically since 1996, it is still not possible to predict with any degree of accuracy the final magnitude of this epidemic, with the 95% confidence interval for future cases being from 10 to 7000 deaths. However, short-term projections show that it is unlikely that a dramatic increase in case numbers will be observed in the next 2–5 years (95% confidence interval for 2 years: 10–80 cases, for 5 years: 10–200 cases). The results confirm significant age-dependent susceptibility/exposure to infection, with the likelihood profile demonstrating that those aged between 10 and 20 years are at highest risk of infection. We also demonstrate how projections based on onset data may be substantially biased, and explore the sensitivity of results to assumptions concerning the exposure to bovine spongiform encephalopathy (BSE) and the incubation-period distribution.

[1]  J Mackenzie,et al.  Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994–2000 , 2001, The Lancet.

[2]  Jean Maccario,et al.  The Incubation Period of Kuru , 2002, Epidemiology.

[3]  S. Cousens,et al.  Diagnosis of new variant Creutzfeldt‐Jakob disease , 2000, Annals of neurology.

[4]  C. Farrington,et al.  Incidence of variant Creutzfeldt-Jakob disease in the UK , 2000, The Lancet.

[5]  A. Ghani,et al.  Accumulation of prion protein in tonsil and appendix: review of tissue samples , 2002, BMJ : British Medical Journal.

[6]  R. Anderson,et al.  Estimation of the number of people incubating variant CJD , 1998, The Lancet.

[7]  P. MartínezMartín.  [A new variant of Creutzfeldt-Jakob disease]. , 1997 .

[8]  J. Collinge,et al.  Pathogenesis: HLA-DQ7 antigen and resistance to variant CJD , 2001, Nature.

[9]  E. Fisher,et al.  Identification of multiple quantitative trait loci linked to prion disease incubation period in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Pandu R. Tadikamalla,et al.  A Probability Distribution and its Uses in Fitting Data , 1979 .

[11]  A. Iserles.  Numerical recipes in C—the art of scientific computing , by W. H. Press, B. P. Flannery, S. A. Teukolsky and W. T. Vetterling. Pp 735. £27·50. 1988. ISBN 0-521-35465-X (Cambridge University Press) , 1989, The Mathematical Gazette.

[12]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[13]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[14]  S. Cousens,et al.  Predictability of the UK Variant Creutzfeldt-Jakob Disease Epidemic , 2001, Science.

[15]  M. Doherr,et al.  Modelling the expected numbers of preclinical and clinical cases of bovine spongiform encephalopathy in Switzerland , 1999, Veterinary Record.

[16]  N M Ferguson,et al.  Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[17]  M. Bishop,et al.  Variant Creutzfeldt-Jakob disease in an elderly patient , 2001, The Lancet.

[18]  C. Donnelly,et al.  Transmission dynamics and epidemiology of BSE in British cattle , 1997, Nature.

[19]  Arieyeh J Austin,et al.  Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy , 1994, Veterinary Record.

[20]  A. McLean,et al.  Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  J W Wilesmith,et al.  Bovine spongiform encephalopathy: epidemiological studies on the origin , 1991, Veterinary Record.

[22]  M. Dawson,et al.  Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update , 1998, Veterinary Record.

[23]  G. Bryant.  SUMMARY OF THE FINAL REPORT OF THE INVESTIGATION INTO THE NORTH LEICESTERSHIRE CLUSTER OF VARIANT CREUTZFELDT-JAKOB DISEASE The investigation was carried out , 2001 .

[24]  Y. Agid,et al.  Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in France , 1999, Neurology.

[25]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[26]  Markus Glatzel,et al.  Plasminogen binds to disease-associated prion protein of multiple species , 2001, The Lancet.

[27]  Christl A. Donnelly,et al.  Predicted vCJD mortality in Great Britain , 2000, Nature.

[28]  William H. Press,et al.  The Art of Scientific Computing Second Edition , 1998 .

[29]  V. Isham,et al.  Estimation of the incidence of HIV infection. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[30]  A. Ghani,et al.  Estimating the human health risk from possible BSE infection of the British sheep flock , 2002, Nature.

[31]  N M Ferguson,et al.  The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[32]  M. Beekes,et al.  Effect of repeated oral infection of hamsters with scrapie. , 1998, The Journal of general virology.

[33]  M. Palmer,et al.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.

[34]  R. Anderson,et al.  Epidemiological and statistical aspects of the AIDS epidemic: introduction. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  R. Lathe,et al.  Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene , 1996, Human Genetics.

[36]  A. Ghani,et al.  Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[37]  R. G. Will,et al.  Predicting the CJD epidemic in humans , 1997, Nature.

[38]  T. Crow,et al.  Codon 129 changes in the prion protein gene in Caucasians. , 1990, American journal of human genetics.

[39]  A. Hamad,et al.  Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2001, Neurology.

[40]  A. Valleron,et al.  Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United Kingdom , 2001, Science.

[41]  G. Wells,et al.  Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. , 1998, The Veterinary record.

[42]  R. Kimberlin,et al.  Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. , 1978, Journal of comparative pathology.